Gene · 762
Papers2,162
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,162
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Integrative Analysis of Identified Schizophrenia-Associated Brain Cell Types and Gene Expression Changes. | Int J Mol Sci | 2022 | 36232882 | PubTator, text mining | PubMed |
| Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation. | Cell Rep Med | 2022 | 36223777 | PubTator, text mining | PubMed |
| The RNA m6A writer WTAP in diseases: structure, roles, and mechanisms. | Cell Death Dis | 2022 | 36207306 | PubTator, text mining | PubMed |
| Synthesis and anticancer activity of new benzensulfonamides incorporating s-triazines as cyclic linkers for inhibition of carbonic anhydrase IX. | Sci Rep | 2022 | 36202955 | PubTator, text mining | PubMed |
| Development of benzene and benzothiazole-sulfonamide analogues as selective inhibitors of the tumor-associated carbonic anhydrase IX. | Eur J Med Chem | 2022 | 36201858 | PubTator, text mining | PubMed |
| Design, synthesis and biological evaluation of novel diarylpyridine derivatives as tubulin polymerisation inhibitors. | J Enzyme Inhib Med Chem | 2022 | 36196773 | PubTator, text mining | PubMed |
| EMMPRIN is an emerging protein capable of regulating cancer hallmarks. | Eur Rev Med Pharmacol Sci | 2022 | 36196720 | PubTator, text mining | PubMed |
| Design, synthesis and biological evaluation of 9-aryl-5H-pyrido[4,3-b]indole derivatives as potential tubulin polymerization inhibitors. | Front Chem | 2022 | 36186601 | PubTator, text mining | PubMed |
| Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer. | Front Genet | 2022 | 36171885 | PubTator, text mining | PubMed |
| Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy. | J Immunother Cancer | 2022 | 36171009 | PubTator, text mining | PubMed |
| Synthesis and Molecular Docking Study of New Thiazole Derivatives as Potential Tubulin Polymerization Inhibitors. | ACS Omega | 2022 | 36157722 | PubTator, text mining | PubMed |
| Design and synthesis of new trimethoxylphenyl-linked combretastatin analogues loaded on diamond nanoparticles as a panel for ameliorated solubility and antiproliferative activity. | J Enzyme Inhib Med Chem | 2022 | 36154552 | PubTator, text mining | PubMed |
| Synthesis, Characterisation and Mechanism of Action of Anticancer 3-Fluoroazetidin-2-ones. | Pharmaceuticals (Basel) | 2022 | 36145265 | PubTator, text mining | PubMed |
| Metabolic Profiling of Jasminum grandiflorum L. Flowers and Protective Role against Cisplatin-Induced Nephrotoxicity: Network Pharmacology and In Vivo Validation. | Metabolites | 2022 | 36144196 | PubTator, text mining | PubMed |
| RPE65 c.353G>A, p.(Arg118Lys): A Novel Point Mutation Associated with Retinitis Pigmentosa and Macular Atrophy | Int J Mol Sci | 2022 | 36142423 | PubTator, text mining | PubMed |
| Effects of Carbonated Thickened Drinks on Pharyngeal Swallowing with a Flexible Endoscopic Evaluation of Swallowing in Older Patients with Oropharyngeal Dysphagia. | Healthcare (Basel) | 2022 | 36141382 | PubTator, text mining | PubMed |
| A Novel 3-Gene Signature for Identifying COVID-19 Patients Based on Bioinformatics and Machine Learning. | Genes (Basel) | 2022 | 36140771 | PubTator, text mining | PubMed |
| A Cationic Contrast Agent in X-ray Imaging of Articular Cartilage: Pre-Clinical Evaluation of Diffusion and Attenuation Properties. | Diagnostics (Basel) | 2022 | 36140512 | PubTator, text mining | PubMed |
| Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential. | Biomolecules | 2022 | 36139062 | PubTator, text mining | PubMed |
| Elevated CO2 and Water Stress in Combination in Plants: Brothers in Arms or Partners in Crime? | Biology (Basel) | 2022 | 36138809 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/762/papers?page=21